Cincinnati start-up nearing commercialization of devices for brain monitoring
Founded in 2014 by four University of Cincinnati physicians, Sense Neuro Diagnostics has raised around $10 million for multiple noninvasive devices to monitor traumatic brain injuries and detect brain hemorrhage or different types of strokes.
A Cincinnati start-up has raised another $250,000 to advance its clinical trials as the company moves toward the commercialization of multiple noninvasive devices to monitor traumatic brain injuries and detect brain hemorrhage or different types of strokes.
Founded in 2014 by four University of Cincinnati physicians, Sense Neuro Diagnostics’ latest funding comes from St. Elizabeth Healthcare and brings its total capital raised to around $10 million. According to an article in Cincy Inno, the funding to date comes from a variety of investors including Queen City Angels, Accelerant Ventures, Cleveland Clinic, Global Cardiovascular Innovation Fund, and a private group of Cincinnati-based neuro physicians.
A significant portion of Sense Neuro’s funding came when the U.S. Army Medical Research and Development Command (USAMRDC) Combat Casualty Care Research Program awarded the start-up $2.43 million in August 2021 to advance its technology to diagnose and monitor traumatic brain injury (TBI) in a field environment. The award was issued through Medical Technology Enterprise Consortium (MTEC), a biomedical technology consortium working to advance innovative medical solutions to keep military personnel healthy and fully operational.
The Cincy Inno article said Sense Neuro plans a commercial launch in 2024.
